← Eichor
Study identifier: NCT07291687 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

tDCS as Treatment for Motor Function

Condition: Progressive Supranuclear Palsy · Cortical Basal Ganglionic Degeneration · Parkinson Disease  ·  Sponsor: Baycrest

PhaseNA
Planned participants20
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Previous preliminary results are sufficiently impressive to suggest that tDCS stimulation does have the potential to improve motor function when that ability is trained during stimulation. In the proposed study, the investigation will assess whether walking sessions combined with tDCS lead to improvements in motor function: gait, articulation, eye gaze, and motor dexterity. In addition, the investigators wish to examine if such results can be replicated in people with other conditions, such as cortical basal syndrome, and Parkinson's disease.

This description comes directly from the study's public registry record.

Talk to the study team

Alice Zhang, B.Sc  ·  (416) 785-2500  ·  azhang4@research.baycrest.org

Tyler Roncero, Ph.D  ·  T (416) 785-2500  ·  croncero@research.baycrest.org

Always discuss trial participation with your own doctor first.

Locations (1)

Baycrest Academy of Health Sciences and Geriatric ResearchToronto, Ontario, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07291687